
Valprol 499.50mg/217.50mg Tablet CR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Sodium Valproate (499.50mg) + Valproic Acid (217.50mg)
Overview Valprol 499.50mg/217.50mg Tablet CR
Epileptin CR 499.50mg/217.50mg tablets contain a dual-action formula to manage epilepsy, a neurological condition characterized by recurring seizures. This medication regulates aberrant brain activity, promoting nerve relaxation and seizure prevention. Epileptin CR should be administered with food; dosage is determined by your physician, often increasing gradually until your condition stabilizes. Therapeutic effects may take weeks to manifest; consistent use is crucial. Discontinuation, even if feeling well, requires medical supervision as it may precipitate increased seizure frequency or exacerbate bipolar symptoms. Common side effects include nausea and tremors; others such as vomiting, headaches, liver complications, and upper abdominal discomfort may occur. Most side effects are transient, but persistent or bothersome symptoms warrant medical attention. Preventive measures may be available. Prior to commencing treatment, inform your doctor of any kidney or liver disease, meningitis, depression, or suicidal ideation. All other medications, including contraceptives, should be disclosed due to potential interactions. Use during pregnancy or breastfeeding requires careful consideration and potential dosage adjustments. Avoid driving or cycling if drowsiness or dizziness occur. Regular blood tests may be necessary to monitor treatment efficacy. Alcohol consumption should be avoided due to potential side effect exacerbation. Weight gain is a possibility; maintain a balanced diet, limit high-calorie snacks, and engage in regular physical activity. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts or actions to your physician immediately.
Uses of Valprol 499.50mg/217.50mg Tablet CR
Seizure disorder
Major Benefits of Valprol 499.50mg/217.50mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Valprol 499.50mg/217.50mg Controlled-Release Tablets with food.
Common Side effects of Valprol 499.50mg/217.50mg Tablet CR:
- Nausea
- Tremors
How to use Valprol 499.50mg/217.50mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Valprol 499.50mg/217.50mg Controlled-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Valprol 499.50mg/217.50mg Tablet CR works:
Each Valprol CR tablet (499.50mg/217.50mg) contains sodium valproate and valproic acid, both anticonvulsant medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Valprol 499.50mg/217.50mg CR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Valproate 499.50mg/217.50mg Controlled-Release tablets during pregnancy carries a confirmed risk to the unborn child. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits clearly outweigh the risks. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Depakote ER 499.50mg/217.50mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Taking Valprol 499.50mg/217.50mg Controlled-Release tablets can lead to drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Valprol 499.50mg/217.50mg CR tablets in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary, but physician consultation is recommended. Patients with pre-existing kidney conditions should discuss this medication with their doctor.
LiverCAUTION
Patients with liver impairment should use Valprol 499.50mg/217.50mg CR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Valprol 499.50mg/217.50mg CR tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Valprol 499.50mg/217.50mg Tablet CR :
Should you forget to take your Valprol 499.50mg/217.50mg CR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Valprol 499.50mg/217.50mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
